{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:24Z","timestamp":1786119924801,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>Embryonal tumors with multilayered rosettes (ETMR) represent a distinct entity characterized by aggressive behavior. Historical retrospective analyses have documented dire overall survival rates ranging from 0% to 14% at 1 year. However, a contemporary report by Khan and colleagues shows overall survival rates reaching 29% at 2 years and 27% at 4 years. We present the case of an 18-month-old girl diagnosed with ETMR, confirmed by chromosome 19 microRNA cluster amplification following initial presentation with focal seizures. The patient underwent a combination of surgical interventions, high-dose chemotherapy with stem cell rescue, and proton therapy, achieving a disease-free status after completing standard treatment. Subsequently, a 12-month maintenance regimen comprising intrathecal topotecan, oral sodium valproate, and oral cis-retinoic acid was administered. The maintenance therapy was well tolerated, with manageable adverse effects. The patient remains progression-free for 32 months postmaintenance therapy (50\u00a0months from initial presentation). This study explores the feasibility and safety profile of maintenance therapy in ETMR. Future studies may explore this approach to determine its efficacy in children with ETMR.<\/jats:p>","DOI":"10.1097\/mph.0000000000003033","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T17:15:11Z","timestamp":1744046111000},"page":"242-245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring Maintenance Therapy in Pediatric Embryonal Tumor With Multilayered Rosettes"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3278-3989","authenticated-orcid":false,"given":"Mohamed M.","family":"Ahmed","sequence":"first","affiliation":[{"name":"Children and Young People\u2019s Unit, The Royal Marsden NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Carceller","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Unit, The Royal Marsden NHS Foundation Trust"},{"name":"Division of Clinical Studies, The Institute of Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie R.","family":"Bridges","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, St. George's University Hospitals NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"Mallucci","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Alder Hey Children\u2019s Hospital NHS Foundation Trust, Liverpool"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navneet","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, St. George\u2019s NHS Foundation Trust, London; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sucheta","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Children and Young People\u2019s Unit, The Royal Marsden NHS Foundation Trust"},{"name":"Division of Clinical Studies, The Institute of Cancer Research"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"R1-20250623","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"R2-20250623","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-013-1228-0","article-title":"Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity","volume":"3","author":"Korshunov","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R3-20250623","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5414\/NP300636","article-title":"Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature","volume":"33","author":"Ceccom","year":"2014","journal-title":"Clin Neuropathol"},{"key":"R4-20250623","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00401-010-0710-1","article-title":"Genetic profiling of CNS tumors extends histological classification","volume":"120","author":"Paulus","year":"2010","journal-title":"Acta Neuropathol"},{"key":"R5-20250623","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3174\/ajnr.A7462","article-title":"The 2021 World Health Organization classification of tumors of the central nervous system: what neuroradiologists need to know","volume":"43","author":"Osborn","year":"2022","journal-title":"Am J Neuroradiol"},{"key":"R6-20250623","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-014-1291-1","article-title":"CNS-PNETs with C19MC amplification and\/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity","volume":"3","author":"Spence","year":"2014","journal-title":"Acta Neuropathol"},{"key":"R7-20250623","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/children9101560","article-title":"Clinical management of embryonal tumor with multilayered rosettes: the CCMC experience","volume":"9","author":"Li","year":"2022","journal-title":"Children"},{"key":"R8-20250623","first-page":"1","article-title":"A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes","volume":"2","author":"Hanson","year":"2020","journal-title":"Neurooncol Adv"},{"key":"R9-20250623","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00381-015-2920-2","article-title":"Embryonal tumors with multilayered rosettes in children: the SFCE experience","volume":"32","author":"Horwitz","year":"2016","journal-title":"Child\u2019s Nerv Syst"},{"key":"R10-20250623","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jon.12524","article-title":"Embryonal tumor with multilayered rosettes, C19MC-altered: clinical, pathological, and neuroimaging findings","volume":"28","author":"Wang","year":"2018","journal-title":"J Neuroimag"},{"key":"R11-20250623","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/pbc.21307","article-title":"Intensive chemotherapy followed by consolidative myeloablative chemotherapy with Autologous Hematopoietic Cell Rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): Report of the head start I and II experience","volume":"50","author":"Fangusaro","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20250623","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pbc.24648","article-title":"Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid\/rhabdoid tumors: the head start III experience","volume":"61","author":"Zaky","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"supplement_4","key":"R14-20250623","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noae064.185","article-title":"Etmr-15. Reclassification of childhood central nervous system primitive neuroectodermal tumor: clinical features and outcome","volume":"26","author":"Simbozel","year":"2024","journal-title":"Neuro Oncol"},{"issue":"supplement_3","key":"R15-20250623","doi-asserted-by":"crossref","first-page":"iii325","DOI":"10.1093\/neuonc\/noaa222.218","article-title":"Etmr-14. Treatment of embryonal tumours with multilayered rosettes (ETMR) with carboplatin-etoposide induction and tandem high-dose chemotherapy within the prospective hit-trials and registries","volume":"22","author":"Juhnke","year":"2020","journal-title":"Neuro Oncol"},{"issue":"supplement_3","key":"R16-20250623","doi-asserted-by":"crossref","first-page":"iii327","DOI":"10.1093\/neuonc\/noaa222.223","article-title":"Etmr-20. Impact of high dose chemotherapy with and without methotrexate (MTX) on outcome of patients with embryonal tumors with multi-layered rosettes (ETMRS): a report from children\u2019s oncology group phase iii trial acns0334","volume":"22","author":"Mumal","year":"2020","journal-title":"Neuro Oncol"},{"key":"R17-20250623","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","article-title":"Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 Phase I\/II study. A report from the Children\u2019s Oncology Group","volume":"53","author":"Cohen","year":"2015","journal-title":"Pediatr Neurol"},{"key":"R18-20250623","first-page":"31","article-title":"Radiation for ETMR: literature review and case series of patients treated with proton therapy","volume":"15","author":"Jaramillo","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"R19-20250623","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccr.2009.10.025","article-title":"Frequent amplification of a chr19q13.41 microrna polycistron in aggressive primitive neuroectodermal brain tumors","volume":"16","author":"Li","year":"2009","journal-title":"Cancer Cell"},{"key":"R20-20250623","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3171\/2015.3.PEDS14727","article-title":"Embryonal tumor with abundant neuropil and true rosettes in the brainstem: case report","volume":"16","author":"Sato","year":"2015","journal-title":"J Neurosurg Pediatr"},{"key":"R21-20250623","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/pbc.26118","article-title":"Outcome of young children with high-grade glioma treated with irradiation-avoiding intensive chemotherapy regimens: final report of the Head Start II and III trials","volume":"63","author":"Espinoza","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20250623","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S2352-4642(21)00245-5","article-title":"Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study","volume":"5","author":"Khan","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"R23-20250623","doi-asserted-by":"crossref","first-page":"584681","DOI":"10.3389\/fonc.2020.584681","article-title":"Potential importance of early focal radiotherapy following gross total resection for long-term survival in children with embryonal tumors with multilayered rosettes","volume":"10","author":"Mayr","year":"2020","journal-title":"Front Oncol"},{"key":"R24-20250623","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/pbc.21525","article-title":"Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the \u201chead start\u201d I and II protocols","volume":"50","author":"Dhall","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"supplement_4","key":"R25-20250623","first-page":"0","article-title":"Mdb-83. Outcomes of infants and young children with newly diagnosed shh medulloblastoma treated on the next consortium \u201chead start\u201d 4 protocol","volume":"26","author":"Dhall","year":"2024","journal-title":"Neuro Oncol"},{"key":"R26-20250623","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/neuonc\/noab293","article-title":"Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: a report from the Pediatric Brain Tumor Consortium (PBTC-026)","volume":"24","author":"Leary","year":"2022","journal-title":"Neuro Oncol"},{"issue":"supplement_7","key":"R27-20250623","doi-asserted-by":"crossref","first-page":"vii15","DOI":"10.1093\/neuonc\/noac209.059","article-title":"Biom-49. A pilot study of cerebrospinal fluid exosomal small RNA-sequencing in pediatric medulloblastoma patients on the next consortium \u201chead start\u201d 4 protocol","volume":"24","author":"Bell","year":"2022","journal-title":"Neuro Oncol"},{"key":"R28-20250623","first-page":"vdad052","article-title":"Embryonal tumor with multilayered rosettes: overview of diagnosis and therapy","volume":"5","author":"Chadda","year":"2023","journal-title":"Neurooncol Adv"},{"issue":"supplement_1","key":"R29-20250623","doi-asserted-by":"crossref","first-page":"i53","DOI":"10.1093\/neuonc\/noac079.194","article-title":"ETMR-16. Embryonal tumors with multi-layered rosettes: a case series in treatment for newly diagnosed children","volume":"24","author":"Tran","year":"2022","journal-title":"Neuro Oncol"},{"key":"R30-20250623","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/pbc.23317","article-title":"Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children\u2019s Oncology Group trial (P9962)","volume":"58","author":"Potter","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20250623","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.2003.04.053","article-title":"Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis","volume":"21","author":"Blaney","year":"2003","journal-title":"J Clin Oncol"},{"key":"R32-20250623","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00701-008-1577-y","article-title":"Intrathecal chemotherapy delivered by a lumbar-thecal catheter in metastatic medulloblastoma: a case illustration","volume":"150","author":"Clayton","year":"2008","journal-title":"Acta Neurochir (Wien)"},{"key":"R33-20250623","doi-asserted-by":"crossref","first-page":"e27385","DOI":"10.1002\/pbc.27385","article-title":"Combined high-dose intra-arterial and intrathecal chemotherapy for the treatment of a case of extraocular retinoblastoma","volume":"65","author":"Rodriguez","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R34-20250623","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/pbc.25174","article-title":"Proposed strategy for the use of high-dose chemotherapy with stem cell rescue and intrathecal topotecan without whole-brain irradiation for infantile classic medulloblastoma","volume":"61","author":"Yamada","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R35-20250623","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/08880018.2023.2220734","article-title":"Novel strategy involving high-dose chemotherapy with stem cell rescue followed by intrathecal topotecan maintenance therapy without whole-brain irradiation for atypical teratoid\/rhabdoid tumors","volume":"40","author":"Yamada","year":"2023","journal-title":"Pediatr Hematol Oncol"},{"key":"R36-20250623","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/neuonc\/nox093","article-title":"Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients","volume":"19","author":"Schmidt","year":"2017","journal-title":"Neuro Oncol"},{"key":"R37-20250623","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/neuonc\/not162","article-title":"A novel C19MC amplified cell line links Lin28\/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes","volume":"16","author":"Spence","year":"2014","journal-title":"Neuro Oncol"},{"key":"R38-20250623","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/14728222.2014.938052","article-title":"DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumors","volume":"18","author":"Sin-Chan","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"R39-20250623","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.canlet.2023.216125","article-title":"Valproate and lithium: old drugs for new pharmacological approaches in brain tumors","volume":"560","author":"Natale","year":"2023","journal-title":"Cancer Lett"},{"key":"R40-20250623","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.phrs.2020.104786","article-title":"Epileptogenesis and oncogenesis: an antineoplastic role for antiepileptic drugs in brain tumours","volume":"156","author":"Cucchiara","year":"2020","journal-title":"Pharmacol Res"},{"key":"R41-20250623","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/neuonc\/noad265","article-title":"Integrated proteomics spotlight the proteasome as a therapeutic vulnerability in embryonal tumors with multilayered rosettes","volume":"26","author":"Dottermusch","year":"2024","journal-title":"Neuro Oncol"},{"key":"R42-20250623","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.2014.59.9217","article-title":"Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape","volume":"33","author":"Gajjar","year":"2015","journal-title":"J Clin Oncol"},{"key":"R43-20250623","doi-asserted-by":"crossref","first-page":"887544","DOI":"10.3389\/fneur.2022.887544","article-title":"Toward improved diagnosis accuracy and treatment of children, adolescents, and young adults with ependymoma: the international SIOP ependymoma II protocol","volume":"13","author":"Leblond","year":"2022","journal-title":"Front Neurol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:26:30Z","timestamp":1786044390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0000000000003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003033","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"2024-07-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}